However, presently, the methods available for CRC diagnosis, including carcinoembryonic antigen (CEA) and colonoscopy, are limited owing to their low sensitivity and specificity, high cost and discomfort to the patients.5, 6. This evidence concerns the gene CEACAM5 and colorectal carcinoma.